The plant hormone cytokinin affects a diverse array of growth and development processes and responses to the environment. How a signaling molecule mediates such a diverse array of outputs and how these response pathways are integrated with other inputs remain fundamental questions in plant biology. To this end, we characterized the transcriptional network initiated by the type-B ARABIDOPSIS RESPONSE REGULATORs (ARRs) that mediate the cytokinin primary response, making use of chromatin immunoprecipitation sequencing (ChIP-seq), protein-binding microarrays, and transcriptomic approaches. By ectopic overexpression of ARR10, Arabidopsis lines hypersensitive to cytokinin were generated and used to clarify the role of cytokinin in regulation of various physiological responses. ChIP-seq was used to identify the cytokinin-dependent targets for ARR10, thereby defining a crucial link between the cytokinin primary-response pathway and the transcriptional changes that mediate physiological responses to this phytohormone. Binding of ARR10 was induced by cytokinin with binding sites enriched toward the transcriptional start sites for both induced and repressed genes. Three type-B ARR DNA-binding motifs, determined by use of protein-binding microarrays, were enriched at ARR10 binding sites, confirming their physiological relevance. WUSCHEL was identified as a direct target of ARR10, with its cytokinin-enhanced expression resulting in enhanced shooting in tissue culture. Results from our analyses shed light on the physiological role of the type-B ARRs in regulating the cytokinin response, mechanism of type-B ARR activation, and basis by which cytokinin regulates diverse aspects of growth and development as well as responses to biotic and abiotic factors. 
kinin (9) (10) (11) . Protein levels of type-B ARRs are regulated in part through the ubiquitin-proteasome pathway (15, 17, 18) .
The response of the Arabidopsis transcriptome to cytokinin has been characterized in over a dozen studies involving a variety of plant growth conditions, tissues, and treatment regimes (19, 20) . Although we have extensive information on cytokininregulated gene expression, we have only limited information on which genes are direct targets of the type-B ARRs. Among the genes most consistently induced in response to cytokinin are the type-A ARRs, which encode a second family of response regulators that negatively regulate cytokinin responses (21, 22) . The type-A ARRs are primary-response genes, based on the ability of cytokinin to induce their expression in the presence of cycloheximide (21) . In addition, chromatin immunoprecipitation has been used to identify binding sites of type-B ARRs involved in regulation of the SHY2 and LAX2 genes to control auxin responses (23, 24) and of PR1 and PR2 to control defense responses (25) , indicating that these are also primary-response genes. These studies are consistent with transcriptional regulation by the type-B ARRs, but the extent of such direct transcriptional regulation in control of the cytokinin response remains to be elucidated.
In this study, we took advantage of the enhanced stability of ARR10 compared with the other type-B ARRs to generate Arabidopsis lines hypersensitive to cytokinin and to clarify the role of cytokinin in regulation of various physiological responses. We also used protein-binding microarrays to characterize the DNA binding sites for ARR1 and ARR10. Finally, we used chromatin immunoprecipitation sequencing (ChIP-seq) to identify the cytokinin-dependent targets for ARR10, thereby defining a crucial link between the cytokinin primary-response pathway and the transcriptional changes that mediate physiological responses to this phytohormone. The findings from ChIP-seq also lend insight into the mechanism by which type-B ARRs regulate gene expression, and support the existence of a transcriptional cascade operating downstream of the type-B ARRs.
Results
Elevated Expression of the Type-B Response Regulator ARR10 Results in a Hypersensitive Response to Cytokinin. To explore the effects of cytokinin hypersensitivity on Arabidopsis, we expressed ARR10 as a GFP fusion driven by the CaMV 35S promoter in an arr1 arr10 arr12 loss-of-function mutant background. The rationale for this strategy is as follows. First, ARR10 was used because it functionally overlaps with ARR1 and ARR12 in playing a substantive role in regulating the cytokinin transcriptional response, but the ARR10 protein is likely more stable than these type-B ARRs (26) . Second, the arr1 arr10 arr12 background was used because this triple mutant abolishes the majority of cytokinin-mediated gene expression and renders the plant largely insensitive to cytokinin for physiological responses (10, 11) . The arr1 arr10 arr12 cytokinin-insensitive line can therefore be used to assess functionality of the ARR10-GFP fusion and also eliminates members of the type-B ARR family that could compete with ARR10 for activation and binding sites. Third, the CaMV 35S promoter was used to drive ectopic overexpression, because the native expression of the type-B ARRs is low and likely restrictive for signaling (26, 27) . We also expressed 35S:ARR10: GFP in a wild-type background for comparison. Analysis by qRT-PCR confirmed that the four lines in the arr1 arr10 arr12 background (lines a1, a2, a3, and a4) and the two lines in the wild-type background (lines w1 and w2) exhibited substantially elevated expression of ARR10 compared with its native expression level in wild type (Fig. 1A) .
Analysis of hypocotyl and root growth responses to cytokinin supports hypersensitivity of the 35S:ARR10:GFP transgenic lines. Exogenous cytokinin inhibits hypocotyl growth in the dark and primary root growth of wild-type seedlings, the arr1 arr12 and arr1 arr10 arr12 mutants exhibiting cytokinin hyposensitivity or insensitivity in these assays ( Fig. 1 B and C) . The ARR10:GFP transgene is functional, as it restores cytokinin sensitivity to arr1 arr10 arr12 in the root and hypocotyl assays as well as rescues the mutant's primary root abortion phenotype ( Fig. 1 B and C and Fig. S1 ) (10, 11) . In the absence of cytokinin, two lines (lines a1 and a3) in the arr1 arr10 arr12 background have shorter hypocotyls and all four lines have shorter roots in the absence of exogenous cytokinin than the wild type, consistent with an enhanced response to endogenous cytokinin levels. All four lines in the arr1 arr10 arr12 background exhibit a substantially heightened response in the presence of cytokinin ( Fig. 1 B and D and Fig. S1 ). The pronounced effects on root growth are due to a heightened inhibition of cell expansion as well as of cell proliferation ( Fig. 1 E  and F) . Cytokinin hypersensitivity is also observed when 35S: ARR10:GFP is expressed in the wild-type background, although the effect of the transgene in the absence of exogenous cytokinin is more pronounced in the arr1 arr10 arr12 background ( Fig. 1 B and C and Fig. S1 ).
Cytokinin is a positive regulator of cell proliferation and growth in the shoot, contrasting with its negative regulation of cell proliferation and growth in the primary root. Loss of type-B response regulators (arr1 arr10 arr12 mutant) results in a substantial decrease in leaf size compared with wild type, this effect on growth in the mutant being primarily due to a decrease in cell proliferation, although a decrease in leaf cell area is also observed (Fig. S2 A and  B) . Expression of 35S:ARR10:GFP in the arr1 arr10 arr12 background complemented the leaf growth phenotype of the mutant ( Fig. S2 A and C) . In addition, the later larger leaves of the 35S: ARR10 lines exhibited an increase in cell number compared with wild type, consistent with hypersensitivity to endogenous cytokinin resulting in greater cell proliferation in the shoot.
The hypersensitive ARR10 lines also exhibit an enhanced transcriptional response to cytokinin ( Fig. 1 G and H) . The cytokininmediated induction of ARR7, ARR15, and CKX5 and the repression of HKT1 were examined (8, 20, 28, 29) . ARR7 and ARR15 encode type-A ARRs and are primary-response genes, CKX5 encodes a cytokinin oxidase, and HKT1 encodes a gene whose product is responsible for removing sodium ions from the root xylem. The cytokinin-dependent regulation of these genes is severely attenuated in the cytokinin-insensitive arr1 arr12 mutant (the arr1 arr10 arr12 mutant was not used for comparison because its primary root prematurely aborts) (Fig. 1G) . Consistent with the physiological responses to cytokinin, ARR10-GFP overexpression resulted in increased transcript levels for ARR7, ARR15, and CKX5 and decreased transcript levels for HKT1 following cytokinin treatment at all cytokinin concentrations examined, this effect being observed in both the arr1 arr10 arr12 and wild-type backgrounds ( Fig. 1 G and  H) . The basal transcript level of HKT1 was also substantially reduced in the ARR10 transgenic lines, consistent with a heightened response to endogenous cytokinin. Taken together, these results are consistent with the hypothesis that the cytokinin hypersensitivity found in the ARR10 lines is due to an enhanced ability to mediate cytokininregulated gene expression. Furthermore, the use of the arr1 arr10 arr12 loss-of-function background appeared to result in a heightened hypersensitivity compared with use of the wild-type background based on the hypocotyl, root, and molecular response assays.
Genome-Wide Identification of Candidate Targets for ARR10. We exploited the hypersensitive 35S:ARR10:GFP lines as a means to identify direct targets of type-B ARRs by chromatin immunoprecipitation/DNA sequencing. For the ChIP-seq analysis, we examined the hypersensitive lines a1 (two biological replicates) and a2 (one biological replicate) following treatment for 30 min with 5 μM 6-benzylaminopurine (BA). A 30-min treatment was used because transcriptional induction by cytokinin of primary targets can be observed within 10 min and often peaks within 2 h (28). Binding peaks were identified by model-based analysis of ChIP-seq (MACS), with the peak summits defined as the point of local Results for four independent lines of 35S:ARR10:GFP in the arr1;10;12 background (a1, a2, a3, and a4) and two independent lines in the wild-type background (w1 and w2) are shown. Expression was normalized to a tubulin (At5g62700) internal control, and is presented as relative to the wild-type control. (A, Inset) Relative ARR10-GFP protein levels from 7-d-old seedlings based on immunoblot analysis with an anti-GFP antibody (GFP-Ab); LC, loading control. (B) Hypocotyl growth dose-response assay to cytokinin (BA) (n = 30). Error bars indicate SE (not shown if smaller than symbol). (C) Root growth dose-response assay to cytokinin (BA) (n = 30). The increase in root length from day 4 to 7 was measured. Error bars indicate SE (not shown if smaller than symbol). (D) Primary root tips of 7-d-old wild-type and 35S:ARR10:GFP-a1 seedlings treated with DMSO vehicle (−) or 1 μM BA (+). (Scale bars, 0.2 mm.) (E and F) Hypersensitive lines have shorter roots due to effects on both root cell elongation (E) and cell proliferation (F). Root epidermal cell lengths from the elongation zone (n ≥ 10; P < 0.05) and root apical meristem (RAM) size based on the number of cortex cells (n ≥ 5; P < 0.05) were determined for 7-d-old roots at the BA concentrations indicated. Error bars indicate SE. Same letters indicate no significant difference by an ANOVA applying Tukey HSD post test (na, conditions with no data due to phenotypic severity). (G) 35S:ARR10:GFP lines exhibit a hypersensitive molecular response to cytokinin compared with wild type (Wt) and the cytokinin-insensitive arr1 arr12 mutant in a dose-response analysis. Expression is plotted on a log10 scale. Relative transcript levels of cytokinin-responsive genes from 6-d-old roots were examined by qRT-PCR. Seedlings were treated for 2 h with the indicated BA concentrations. Expression was normalized to a tubulin (At5g62700) internal control, and is presented as relative to the Wt untreated control. Transcript levels of the cytokinin-inducible genes ARR7, ARR15, and CKX5 and the cytokinin-repressed gene HKT1 were examined. Error bars indicate SE. (H) Analysis of 35S:ARR10: GFP lines w1, w2, and a2 compared with wild type by qRT-PCR ( o P < 0.05, oo P < 0.01, for comparison of BA treatment with untreated for each line, t test; *P < 0.05, **P < 0.01, for comparison of transgenic lines with the analogous wild-type treatment condition, one-way ANOVA with post hoc Holm multiplecomparison calculation; n = 3). maximum read density (30) . Substantial overlap was found for the DNA regions bound in the three samples, with 4,861 summits in common for all three samples ( Fig. 2A) . The peak summits were found in introns, exons, and intergenic regions, the greatest number of summits being found in the intergenic regions that would include the gene promoters (Fig. 2B) , this also being the case when normalized per kilobase of region type (19% introns, 19% exons, 67% intergenic regions). The maximum peak frequency occurred near the transcription start sites (TSSs) (Fig. 2C) , such binding being consistent with a classic regulatory role for ARR10 in the control of gene expression.
ARR10 is predicted to bind to DNA regions associated with the type-A ARRs, which are cytokinin primary-response genes (8, 21, 22) . As shown in Fig. 2D , ARR10 binding peaks are found associated with the type-A ARRs, with 9 out of 10 of the ARR10 binding peak summits occurring in the promoter regions of the type-A ARRs. The peaks exhibit a range of Q values, spanning much of the frequency region defined by the overlapping set of 4,861 binding sites. Thus, the ARR10-GFP ChIP-seq analysis extracts a set of known targets (type-A ARRs), consistent with the ChIP-seq binding sites being of functional significance. ARR DNA-Binding Motifs. ARR10 targets are predicted to be enriched for type-B ARR-binding motifs. To characterize the DNAbinding motifs for ARR1 and ARR10, we used the PBM11 proteinbinding microarray (31, 32) . ARR1 bound with high affinity to primary (AGATACGG; E score 0.49250), secondary (AAGATCTT; E score 0.49080), and tertiary (CGGATCCG; E score 0.48626) motifs (Fig. 2E ). These motifs all contain a core (A/G)GAT sequence previously identified as critical and sufficient for type-B ARR binding (14) . The ARR10 protein fusion exhibited partial insolubility with decreased binding efficiency to the protein-binding microarray (PBM), yielding a background of high-G/C-content probes. However, when this background is removed, the same primary motif is identified for ARR10 as for ARR1 (Fig. 2E) . These three extended binding motifs are the same as those recognized by the type-B response regulators ARR11 and ARR14 (32) and are also consistent with the more abbreviated ARR-binding motifs identified by Weirauch et al. (33) , indicating that the subfamily-1 type-B ARRs all share a similar DNA-binding specificity. Sequences based on the primary, secondary, and tertiary DNAbinding motifs for the type-B ARRs are all enriched at the ARR10 binding sites identified by ChIP-seq (Fig. 2F) , confirming their physiological relevance. Although they were enriched for these extended motifs, we note that many of the summits lack such motifs. These summits are likely to contain core regions (6 bp or less) of the binding motif that, although sufficient for binding, are often too short to be clearly diagnostic for enrichment or contain type-B ARR binding sites diverged from the consensus.
DNA Binding of ARR10 Is Associated with Genes Transcriptionally
Regulated by Cytokinin. We identified 4,004 candidate gene targets based on their proximity to the ARR10 binding peaks (Dataset S1) , and refer to these as ARR10 candidate targets. Gene targets were then identified by comparison with datasets for genes that are differentially expressed (DE) in response to cytokinin. For this purpose, we made use of an RNA-seq dataset derived from whole seedlings (1,162 DE genes) (20) , a new RNA-seq dataset derived from roots (1,221 DE genes) and shoots (39 DE genes), and two microarray datasets derived from shoot tissue (720 and 121 DE genes) (11, 20) . We also compared the candidate targets to the "golden list," a set of genes identified by meta-analysis of 13 cytokinin transcriptome studies that represent robustly DE genes (226 DE genes) (20) . In addition, we took advantage of a microarray study in which cytokinin-dependent gene regulation was compared in wild type to the arr1 arr10 arr12 mutant (11), incorporating genes that are differentially regulated between these two genotypes into our analysis (1,001 DE genes). In all, 2,848 nonredundant DE genes were identified through these expression studies. Of these, 804 corresponded to a candidate gene target (Dataset S2); we refer to these 804 genes as ARR10 targets. The ARR10 candidate targets were substantially enriched for cytokinin DE genes based on our analysis of the golden list for cytokinin-regulated gene expression as well as the RNA-seq information. The golden list contains 158 up-regulated and 68 down-regulated genes (20) . Of the up-regulated genes, 76 (48%) correspond to an ARR10 candidate target; of the down-regulated genes, 17 (25%) correspond to an ARR10 candidate target. For the up-regulated DE genes, those supported by a higher number of microarray experiments are more likely to be associated with an ARR10 binding peak (Dataset S2). Overall, golden list genes are more likely to be near ARR10 peaks than randomly chosen genes (2.3% of the candidate genes have a golden list entry compared with 0.7% predicted for a random occurrence), these genes are more often up-than down-regulated, and ARR10 peaks are most commonly upstream rather than internal to the golden list genes. Similarly, in a comparison of the type-B ARR candidate targets with 1,162 DE genes identified as cytokinin-regulated in an RNAseq analysis (20) , 310 of the DE genes (26.7%) corresponded to an ARR10 candidate target (significantly higher than the 14.5% predicted by chance), with 78.1% of the DE genes being up-regulated.
We characterized the cytokinin-induced and -repressed ARR10 target genes in terms of their position relative to the TSS and for enrichment of type-B ARR-binding motifs (Fig. S3 ). There is no apparent difference between the up-and down-regulated target genes in terms of ARR10-binding location relative to the TSS, both exhibiting what one might expect from a random selection from the overall set of peak-gene associations. However, substantial differences are observed when we examine type-B ARR motif enrichment for the up-and down-regulated genes. The primary, secondary, and tertiary ARR-binding motifs are enriched at binding sites near DE genes (ARR10 targets), but this enrichment is mostly due to the contribution from the up-regulated genes, which are enriched for all three motifs (Fig. S3B) . Interestingly, although the tertiary binding motif is more rare, it alone of the three motifs exhibited significant enrichment at binding sites among the down-regulated genes.
Gene Ontology Analysis. Gene ontology (GO) analysis for the ARR10 targets and candidate targets revealed enrichment for similar biological processes ( Fig. 3A and Dataset S3). The similarity of the GO-enriched processes suggests that the genes identified in the ARR10 candidate-target dataset that lacked verification by expression information (ARR10 target dataset) are also likely to be of physiological relevance. Cytokinin-dependent regulation of their expression may require additional regulatory factors, occur during a different developmental state, or exhibit longer-term kinetics for induction, because transcriptomic analyses have focused on the short-term response to cytokinin. The GO analysis points to extensive involvement of ARR10 in the control of hormonal responses, including abscisic acid (ABA), auxin, gibberellin, cytokinin, ethylene, brassinosteroids, jasmonic acid, and salicylic acid. Examination of the targets associated with cytokinin, auxin, and ABA reveals multiple regulatory points, including biosynthesis, degradation/inactivation, transport, and signal transduction (Fig.  3B ). These data point to the extensive cross-talk that can occur between cytokinin and other hormonal signaling pathways in the control of growth and development. The GO analysis also links ARR10 activation, and hence cytokinin, to both abiotic (salt and drought stress, cold, and light) and biotic stimuli (Fig. 3A) .
Our data also support a transcriptional cascade operating in the cytokinin signaling pathway based on GO analysis for molecular function, in which "sequence-specific DNA-binding transcription factor activity" (GO:0003700) is the most highly enriched category. This is the case for both the ARR10 candidate target (11.3% of the genes compared with 6.6% expected; P value 2.1E-18) and ARR10 target (15.2% of the genes compared with 6.6% expected; P value 2.2E-13) genes. Multiple families of transcription factors are implicated as ARR10 targets, with members of the bHLH, AP2-EREBP, and WRKY families being among the most abundant (Fig. 3C) . Additionally, when the transcription factor (TF) subset of genes is examined based on GO analysis for biological processes, we find the TF gene sets are implicated in the same types of responses found for the overall ARR10 candidate-target and target genes (e.g., responses to organic substances, hormones, abiotic stimuli, light, and other organisms). This supports a model in which type-B ARR regulation of these processes is controlled in part by regulation of the expression of additional TFs that then provide specificity to the downstream responses.
ARR10 Exhibits Cytokinin-Dependent Binding to DNA Targets. To determine how cytokinin regulates the DNA binding for the type-B ARRs, ChIP-seq for 35S:ARR10:GFP (line a2) was performed in the absence or presence of cytokinin (BA). Cytokinin did not affect the protein levels of ARR10-GFP protein under the conditions used for ChIP (Fig. 4A) . The ChIP-seq analysis revealed cytokinin treatment resulting in an overall increase in DNA binding for ARR10. There was a 2.32-fold enrichment on average for binding to targets and a 2.05-fold enrichment for binding to candidates in response to cytokinin.
Cytokinin-dependent binding for ARR10 was particularly pronounced for target genes induced by cytokinin ( Fig. 4B and Fig.  S3C ). The ChIP-seq binding profiles for ARR10, in the absence and presence of cytokinin, for a select group of induced genes are shown in Fig. 4C . Binding profiles are shown for the type-A response regulators ARR5, ARR7, and ARR15, primary-response genes all of which have a type-B ARR binding site(s) located near the TSS. Binding profiles are also shown for SHY2, a primary-response gene that encodes a regulator of auxin responses (23) and that has two separate peaks of ARR10 binding in its promoter. Similarly, UBC16, which encodes an F-box protein whose expression is reproducibly induced in response to cytokinin (20) , also has two separate peaks in its promoter. In all these cases, although the basal level of binding varies, there is a substantial increase in binding following the 30-min treatment with exogenous BA. We used ChIP-qRT-PCR to confirm the cytokinin-dependent binding of ARR10 to these five targets (ARR5, ARR7, ARR15, SHY2, and UBC16) in line a2 (Fig. 4D) . Similarly, we also confirmed cytokinin induction of ARR10 binding to these targets by using a separate transgenic expression line, in this case an ARR1: ARR10-Myc line (Fig. 4E) . Here ARR10 expression is driven from the ARR1 promoter, resulting in lower and more restricted expression than is found using the CaMV 35S promoter (26) . Thus, these ChIP-based analyses demonstrate that cytokinin stimulates ARR10 binding to the promoters of primary targets, consistent with a model in which cytokinin-mediated posttranslational changes (e.g., phosphorylation of the receiver domain) regulate the DNA target affinity of ARR10.
There is also a trend toward increased binding of ARR10 for those targets repressed by cytokinin (Fig. 4B and Fig. S3C ), although this is not as pronounced as for the induced genes, suggesting the involvement of other regulatory factors and/or longer-term kinetics for such changes to occur. We confirmed cytokinin-dependent binding of ARR10 to the promoter region of SCL3 and to an intron of AUX1 (Fig. 4 D and F) , having recently shown that cytokinin inhibits the expression of AUX1 (34).
Type-B ARRs Target WUSCHEL to Control Shoot Initiation. WUSCHEL (WUS) is among the genes revealed to be a candidate target of ARR10 based on the ChIP-seq analysis (Fig. 5A ). WUS is a homeodomain transcription factor that plays a key role in the establishment and maintenance of the shoot apical meristem (SAM) (35, 36) . Previous work has demonstrated a role of cytokinin in maintaining activity of WUS within the organizing center of the SAM, with WUS expression increasing in response to exogenous cytokinin application (37) . However, it was not previously known whether WUS was a direct target for the type-B ARRs. Our ChIPseq analysis reveals a cytokinin-dependent binding peak for ARR10 upstream of the WUS TSS, consistent with classical regulation of WUS gene induction by ARR10. This region of the WUS promoter does not contain extended type-B binding motifs (Fig.  2E ), but does contain shorter core type-B ARR binding sites that, as noted earlier, are sufficient for interaction (14) .
Cytokinin-dependent binding of ARR10 to the WUS promoter suggests a role for type-B ARRs in regulating WUS expression. We performed a functional analysis of this hypothesis with the type-B ARR loss-of-function mutants as well as the 35S:ARR10:GFP hypersensitive lines (Fig. 5 B and C) . Treatment of wild-type seedlings with cytokinin induces the expression of WUS, but the kinetics of WUS induction differs markedly from that of the well-characterized type-A ARRs that, like many other cytokinin-regulated primaryresponse genes, exhibit a rapid induction that peaks within a few hours of treatment and then decreases (28); WUS exhibited substantially higher expression after a 24-h compared with a 2-h cytokinin treatment (Fig. 5 B and C) . Cytokinin induction of WUS was abolished in the cytokinin-insensitive triple mutant arr1 arr10 arr12 and accentuated in the 35S:ARR10:GFP hypersensitive lines, these last exhibiting a pronounced elevation in WUS expression at 24 h compared with wild type (Fig. 5B) . Analysis of single-and doublemutant combinations of type-B ARRs supports functional overlap in the gene family such that ARR1, ARR10, and ARR12 all play roles in mediating the cytokinin-dependent induction of WUS (Fig. 5C) .
Based on the hypersensitivity of the 35S:ARR10:GFP lines to cytokinin, coupled with the cytokinin-dependent binding of ARR10 to WUS, we predicted that the lines might exhibit altered shooting ability. We explored this possibility in tissue culture, as cytokinin plays a critical role in the induction of WUS expression and the induction of shooting in tissue culture (38) . Hypocotyls from 35S: ARR10:GFP lines a1 and a2 both formed shoots on callusinduction medium (CIM) (Fig. 5D) , bypassing the usual requirement for movement onto shoot-induction medium (SIM). This ability to form shoots on CIM occurred across a limited range of auxin and cytokinin concentrations. Notably, under the low auxin
cytokinin level. These other lines included a wild-type control as well as the cytokinin-insensitive lines arr1 arr12 and arr1 arr10 arr12. In addition, we did not observe shooting with the 35S:ARR10:GFP lines in the wild-type background, only in the arr1 arr10 arr12 background (Fig. 5D) . On CIM containing a higher level of auxin (30 μg/L 2,4-dichlorophenoxyacetic acid; 2,4-D), no shooting was observed, only callus formation (Fig. 5D) . The cytokinin-insensitive lines exhibited a decreased ability to form callus in comparison with wild type as predicted. The 35S:ARR10:GFP lines exhibited greater levels of callus formation than wild type at the lower cytokinin concentrations (0 to 30 μg/L kinetin) but reduced callus formation in comparison with wild type at the higher cytokinin concentrations (100 to 1,000 μg/L kinetin). No callus or shoot formation was observed when hypocotyls were placed on CIM lacking the auxin 2,4-D.
We examined the molecular characteristics coinciding with shoot induction in 35S:ARR10:GFP lines a1 and a2, the prediction being that these would exhibit heightened expression of key genes involved in the production of the SAM. For this purpose, hypocotyls were placed on CIM containing 10 μg/L 2,4-D and 100 μg/L kinetin, conditions under which we observed good shoot formation in the transgenic lines (Fig. 5D ). At 7 d, the transgenic lines had initiated callus growth at the ends of the hypocotyl explants but did not yet display greening or shoot formation. By 14 d, callus had begun to green and form leaves. WUS expression was slightly elevated in hypocotyls of the 35S:ARR10 lines before incubation on CIM, and was hyperinduced in the transgenic lines after transfer to CIM (Fig. 5E) . CLV3, which is induced in response to WUS (38), was also hyperinduced in the transgenic lines in comparison with the wild-type control when placed on CIM (Fig. 5E ). The ability of cytokinin to induce WUS expression was lost in the arr1 arr10 arr12 triple mutant (Fig. 5E ). These data are thus consistent with cytokinin stimulating shoot formation in the hypersensitive lines through type-B ARR-mediated up-regulation of WUS expression.
Discussion
In this study, we took advantage of the enhanced stability of ARR10 compared with the other type-B ARRs to generate Arabidopsis lines hypersensitive to cytokinin and clarify the role of cytokinin in regulation of various physiological responses. We used protein-binding microarrays to characterize the DNA binding sites for ARR1 and ARR10. Finally, we used ChIP-seq in conjunction with transcriptome analysis to identify the cytokinin-dependent targets for ARR10, thereby defining a crucial link between the cytokinin primary-response pathway and the transcriptional changes that mediate physiological responses to this phytohormone. As discussed below, results from our analyses shed light on the physiological role of the type-B ARRs in regulating the cytokinin response, the mechanism of type-B ARR activation, and the basis by which cytokinin regulates diverse aspects of growth and development as well as responses to biotic and abiotic factors.
Type-B response regulators are limiting for signal transduction, as increasing the expression level results in hypersensitivity to cytokinin. Changes in sensitivity have been previously noted following ectopic and/or heightened expression of type-B ARRs (8, 26) . Heightened levels of ARR10 affect diverse cytokinin responses, including physiological responses such as hypocotyl and root growth, cell number and size in leaves, and shoot regeneration in tissue culture, as well as the molecular response based on cytokinindependent regulation of gene expression. Cytokinin hypersensitivity affected cell expansion and division differentially during leaf development. An increase in cell size was the predominant effect on earlier leaves; interestingly, a historical bioassay for cytokinin activity is the ability to enhance cell expansion in cotyledons, consistent with such an effect on younger tissue (39) . An increase in cell number was the predominant effect of hypersensitivity on later leaves, with a substantial increase in leaf area compared with wild type occurring with the later leaves. A role of type-B ARRs in regulating both cell number and cell size is consistent with loss-of-function analysis, both loss-and gain-of-function approaches indicating a greater role overall for the type-B ARRs in control of cell proliferation than for cell expansion. A decrease in leaf cell number has also been noted in cytokinin-deficient as well as cytokinin-insensitive ahk receptor mutant plants (40, 41) . Our results also point to competition among the type-B ARRs for target binding and gene regulation, based on the finding that ARR10 exhibits a greater hypersensitive response in a mutant background lacking ARR1 and ARR12 than in the wild-type background. The enhanced stability of ARR10 compared with ARR1 and ARR12 may result in its exhibiting greater transcriptional activity (17, 26) .
ARR10 bound DNA in a cytokinin-dependent manner, supporting a binding mechanism similar to that of the prokaryotic response regulators. Like the type-B ARRs, many prokaryotic response regulators contain a receiver domain and a separate DNAbinding domain. The receiver domain is autoinhibitory, phosphorylation on the conserved Asp residue resulting in a conformational change to an "active" state that allows for binding to target sequences (42) . Similarly, according to this model, Asp phosphorylation of the type-B ARRs in response to cytokinin would relieve autoinhibition by the receiver domain and allow for binding of the Myb-like domain to target sequences containing the conserved binding motifs. Consistent with such a model is the fact that type-B ARR proteins are present independent of cytokinin, regulation of type-B ARR activity being primarily through phosphorylation rather than turnover (16, 43) ; this contrasts with a hormoneregulated transcriptional activator such as EIN3 involved in ethylene signaling, which is stabilized in the presence of ethylene (44) . Targets for ARR10 include both up-and down-regulated genes, consistent with the type-B ARRs being required for both induction and repression of cytokinin-dependent gene expression (11) . Although ARR10 binding sites are enriched near the TSS for both up-and down-regulated genes, the extended type-B ARR-binding motifs as determined by PBM analysis were primarily enriched for the up-regulated genes, suggesting that the type-B ARRs exhibit higher affinity for these up-regulated targets. Binding to the downregulated targets may thus involve binding to the minimal type-B ARR motif (14) , with affinity increased by additional transcriptional regulators that provide specificity for negative regulation, the type-B ARRs not having apparent repressor activity themselves.
GO analysis of the ARR10 targets is consistent with the pleiotropic nature of cytokinin. Binding targets relate to hormonal control of growth and development, as well as interactions that control various biotic and abiotic responses. These roles have been previously reported for cytokinin (1, 2) , and one fundamental question has been how a signaling molecule mediates such a diverse array of outputs and how these response pathways are integrated with other inputs. Analysis of our binding data supports several transcriptional mechanisms involved in cytokinin pleiotropy. First, subnetworks of gene targets are identified that mediate hormonal cross-talk with cytokinin to control growth and development, as well as to how cytokinin mediates responses to biotic and abiotic stimuli. For example, hormonal cross-talk by cytokinin is mediated by the regulation of gene expression involved in the biosynthesis, degradation/ inactivation, transport, and signal transduction of multiple other phytohormones. Not only does cytokinin regulate the activity of other hormones, the cytokinin-dependent binding of ARR10 to primary targets and resulting changes in expression (e.g., CKXs, IPT, type-A ARRs) will negatively regulate cytokinin activity itself, thereby allowing for desensitization and adaptation to the hormone. Second, transcription factors were highly enriched among the ARR10 targets, consistent with the type-B ARRs operating at the top of a transcriptional cascade in the cytokinin signaling pathway (11, 20) . The transcription factors can serve as another means to indirectly regulate subnetworks for particular responses. In addition, they may function with the type-B ARRs to combinatorially regulate expression of targets, as recently found with a DELLA protein (45) , which can allow for greater specificity in regulation.
We identified WUS as a direct target of ARR10, functional analysis indicating that ARR1, ARR10, and ARR12 all regulate its expression. WUS encodes a homeodomain TF that plays a key role in the establishment and maintenance of the shoot apical meristem (35, 36) . WUS is transcriptionally induced by cytokinin but does not generally appear in large-scale transcriptomic studies of cytokininregulated genes, likely due to its limited region of expression and long-term kinetic response to the hormone. By enhancing expression of ARR10, we increased the sensitivity of WUS expression to cytokinin and affected WUS-dependent transcriptional processes. Interestingly, the homeobox TFs were more enriched in the ARR10 candidate-target dataset than the ARR10 target dataset, these often being genes such as WUS that are tightly regulated and function within limited tissues and at specific stages of development to control morphogenesis; for example, PHABULOSA is only in the ARR10 candidate-target dataset, but its expression has been found to be repressed by cytokinin to regulate cell proliferation at the root meristem (46) . Heightened expression of WUS in the ARR10 cytokinin-hypersensitive lines facilitated shoot induction, pointing to how modulation of cytokinin sensitivity may serve as a means to enhance plant regeneration in tissue culture.
Materials and Methods
Detailed materials and methods are described in SI Materials and Methods.
Plant Materials, Growth Conditions, and Growth Assays. Wild-type and the arr1-3 arr12-1 and arr1-3 arr10-5 arr12-1 mutant lines of A. thaliana were grown as previously described (11) . To generate the 35S:ARR10:GFP construct, a genomic copy of ARR10 was amplified (Table S1 ) and recombined into pEarleygate103 (47), and the construct was then introduced into wild type and the arr1-3 arr10-5 arr12-1 triple mutant (48) . Effects of cytokinin on root and hypocotyl growth were assayed as described (9, 11) . Root meristem size was determined by counting cortical cell number as described (49) .
Expression Analysis. Quantitative real-time PCR was performed using SYBR Premix Ex Taq (TaKaRa Bio; RR041A) with primer pairs for the genes of interest (Table S1 ) and β-TUBULIN3 (At5g62700) as a normalization control. RNA-seq to examine the cytokinin response in wild-type seedlings was performed as described (20) , but roots and shoots were separated following cytokinin treatment and processed independently; sequence data are available from the National Center for Biotechnology Information (NCBI) Sequence Read Archive under BioProject no. PRJNA286779.
Protein-Binding Microarrays. The DNA-binding domains from ARR1 and ARR10 were amplified from Arabidopsis cDNA (Table S1 ) and cloned into pMAL-c2x (New England Biolabs), and the DNA-binding specificities were determined using protein-binding microarrays (PBM11) (31, 32) .
Chromatin Immunoprecipitation and Analysis. Seedlings were grown for 2 to 3 wk and then treated with either 5 μM BA or a DMSO vehicle control in liquid media for 30 min to examine cytokinin induction. Tissue cross-linking, chromatin isolation, and immunoprecipitation were performed as described (50) . ChIP-seq was performed with line a1 (two biological replicates treated with cytokinin) and line a2 (treated with and without cytokinin) of 35S:ARR10:GFP in the arr1 arr10 arr12 background. Sequencing read information is given in Table  S2 . Sequence data are available from the NCBI Sequence Read Archive under BioProject no. PRJNA263839. ChIP-seq data may also be accessed through the Quickload server for the open-source Integrated Genome Browser (IGB) to aid in visualization (bioviz.org) (51) . Peaks were called by comparing the IP with the input derived from each sample separately using MACS2 (version 2.1.0) (30) . Summit regions were defined by restricting peaks to 100 bp in either direction. Overlapping summit regions from different samples were merged using BEDTools (52), and a consensus peak defined whether this merged overlap included all three cytokinin-treated samples. The 4,861 ARR10 consensus peaks were associated with genes ("candidate targets;" Dataset S1) based on the closest downstream gene from each strand within 1.5 kb of the binding summit, as well as accepting any gene to which the peak was internal. Candidate-gene targets were correlated with several cytokinin expression datasets (Dataset S2)
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Zubo et al. 10 .1073/pnas.1620749114 SI Materials and Methods Plant Materials, Growth Conditions, and Growth Assays. Wild-type and the arr1-3 arr12-1 and arr1-3 arr10-5 arr12-1 mutant lines of Arabidopsis thaliana are all in the Columbia ecotype and were grown as previously described (11) . To examine the ability of cytokinin to induce WUS over a time course of 0, 2, and 24 h, 4-d-old seedlings were collected and submerged in liquid media containing 1× Murashige and Skoog salts with Mes buffer and vitamins (Research Products International; M70800) and 1% (wt/vol) sucrose, along with either 10 μM BA or DMSO as a vehicle control. Seedlings were treated for 24 h with DMSO or BA, or for 22 h with DMSO and subsequently 2 h with BA. Treatment was performed in six-well tissue-culture plates (Falcon; 353046) with constant shaking at 15 rpm.
Effects of cytokinin on root and hypocotyl growth were assayed as described (9, 11) . Root meristem size was determined by counting cortical cell number as described (49) . Root cell length was determined from images captured with a CoolSNAP HQ2 (Photometrics) digital camera of elongation zone cells based on where root hair primordia emerge in wild-type plants (54) , with the cell length measured using ImageJ software (National Institutes of Health). For fluorescence visualization, roots were stained with propidium iodide and visualized with a Nikon A1 confocal microscope.
To determine leaf size, cell area, and cells per leaf, plants were grown under an 18-h light/6-h dark cycle. To account for different growth and developmental rates of the lines, leaf parameters were determined at the point when the first silique was mature. Leaf area was determined for five leaves per measurement. Cell area was determined from palisade cells at the central region of the leaf beside the midvein as described (55) , with 15 palisade cells characterized per leaf (75-cell total for the five leaves). Area determination measurements were made with ImageJ software (imagej.nih.gov/ij/). Statistical analysis was performed by one-way ANOVA with post hoc Holm multiple-comparison calculation (56) using the online calculator (astatsa.com/OneWay_Anova_with_TukeyHSD/).
Hypocotyl explants for tissue culture were isolated from seedlings grown on MS medium (Research Products International) supplemented with 1% (wt/vol) sucrose and 0.8% (wt/vol) phytoagar. Seeds, following stratification, were exposed to light at 20°C for 16 h to coordinate germination and then moved to the dark for additional growth. Hypocotyls were excised from 4-d-old seedlings and transferred to callus-induction medium (CIM), which consisted of MS medium with 2% (wt/vol) sucrose and 0.4% (wt/vol) phytoagar containing different combinations of 2,4-D (10 or 30 μg/L) and kinetin (0, 3, 10, 30, 100, 300, or 1,000 μg/L). All plates contained 0.0127% (vol/vol) DMSO as the vehicle for hormone addition.
Constructs and Generation of Transgenic Lines. To generate the 35S: ARR10:GFP construct, a genomic copy of ARR10 was amplified from ecotype Columbia (Col-0) using the appropriate primers (Table S1) , and the PCR product was cloned into pCR8/GW/TOPO (Invitrogen) and sequenced to ensure that no mutations had occurred. ARR10 was then recombined into the Gateway-compatible destination vector pEarleygate103, to place it under control of the CaMV 35S promoter and incorporate the GFP tag (47) . The construct was transformed into Agrobacterium tumefaciens strain GV1301 and introduced into wild type and the arr1-3 arr10-5 arr12-1 triple mutant by the floral dipping method (48) . Transgenic plants were selected based on their Basta resistance and homozygous lines were generated by selfing.
Quantitative Real-Time PCR Analysis. For gene expression analysis, total RNA was isolated and first-strand cDNA synthesis was performed as previously described (11) . Quantitative real-time PCR (qRT-PCR) was performed using SYBR Premix Ex Taq (TaKaRa Bio; RR041A) according to the manufacturer, using primer pairs specific for the genes of interest (Table S1 ). Three biological replicates with three technical replicates each were used for the expression analysis in Figs. 1H and 5 ; the dose-response curves for Fig. 1G used cDNA generated from pooled RNA of three biological replicates, with three technical replicates. ChIP-qPCR was performed with two or three biological replicates as indicated. As normalization controls, β-TUBULIN3 (At5g62700) was used for qRT-PCR, and TUA4 (AT1G04820), TUB3 (AT5G62700), and EIF4A1 (AT3G13920) were used for ChIP-qPCR.
Protein Isolation and Immunoblot Analysis. Protein was isolated from seedlings as described (26) . Protein concentration was determined by use of the BCA reagent (Pierce) according to the manufacturer after first adding 0.2% (wt/vol) SDS to the samples and with BSA as a standard. Samples were heated above 65°C in gel-loading buffer, and SDS/PAGE and immunoblotting were performed as previously described (57) . A polyclonal anti-GFP antibody (ab290; Abcam) was used for detection of ARR10 tagged by GFP.
Protein-Binding Microarrays. The DNA-binding domains from ARR1 and ARR10 were amplified from Arabidopsis cDNA (Table S1) and then fused to MBP by cloning into pMAL-c2x using restriction enzymes BamHI and SalI (New England Biolabs). Constructs were verified by sequencing. Recombinant proteins were expressed in the BL-21 Escherichia coli strain using the Dual Media Kit (Zymo Research), with induction by 0.1 mM isopropyl β-D-1-thiogalactopyranoside for 8 h at 37°C. Soluble protein extracts were analyzed by SDS/PAGE and immunoblot with an anti-MBP antibody (Santa Cruz Biotechnology) to confirm induction efficiency. The DNA-binding specificities were then determined using protein-binding microarrays (PBM11) as described (31, 32) .
To test for enrichment of the motifs determined by the PBM11 microarrays, the frequency of these motifs was compared for binding and nonbinding regions. Binding regions ("summits") were defined as the 200-bp regions centered over the consensus peaks (the 4,861 peaks that appeared in all three BA-treated samples). The nonbinding "background" is derived from nonbinding regions surrounding consensus peaks but not overlapping any peak from any sample. The set was reduced through random selection to the same number of regions as the number of binding regions (4, 861) , and the regions were defined to be the same size as the binding regions (200 bp). For the enrichment analysis, sequences from each group that contained any 7-mer derived from the primary (AGATWCG), secondary (AAGATCTT), or tertiary (CGGATCCG) type-B ARR-binding motifs were used. From each motif there are two potential 7-mers; for the primary motif, W can be read as A or T. The proportion of sequences from binding and nonbinding regions was compared using a t test. Motif occurrences in the genome were determined in R, version 3.1.2 (58) using the Biostrings package, version 2.34.1 (bioconductor.org/packages/ release/bioc/html/Biostrings.html) (59) in conjunction with rtracklayer, version 1.26.3 (60) and base R functions (locateGroup function in src/MotifHunt.R of the repository), and the overlap between these locations and the binding or nonbinding regions was determined using BEDTools, version 2.25.0 (52).
Chromatin Immunoprecipitation and Analysis. Seedlings were grown on vertical plates with 1× MS media for 2 to 3 wk under 50 μE light intensity, and then treated with either 5 μM BA or a DMSO vehicle control in liquid media for 30 min to examine cytokinin induction. Tissue cross-linking, chromatin isolation, and immunoprecipitation were performed as described (50) . Chromatin shearing was performed using a Bioruptor (Diagenode) for 30 min, with alternating cycles of 30 s sonication and 30 s off at 4°C. Immunoprecipitation was performed using either anti-GFP (ab290; Abcam) or anti-Myc (ab9132; Abcam) antibodies and Magna ChIP protein A+G magnetic beads (EMD Millipore). ChIP-seq was performed with line a1 (two biological replicates treated with cytokinin) and line a2 (treated with and without cytokinin) of 35S:ARR10:GFP in the arr1 arr10 arr12 background. Libraries for ChIP-seq were made using the TruSeq ChIP Kit from Illumina (IP-202-1012), with DNA size selection made using AMPure XP magnetic beads (Agencourt). Library concentrations and quality were assessed using the Qubit 2.0 fluorometer (Life Technologies) and the Bioanalyzer 2100 (Agilent Technologies). Libraries were multiplexed with four barcoded samples per lane and sequencing on the HiSeq 2000 instrument at the High-Throughput Sequencing Facility at the University of North Carolina at Chapel Hill (Table S2) . Sequence data are available from the NCBI Sequence Read Archive under BioProject no. PRJNA263839. ChIP-seq data may also be accessed through the Quickload server for the open-source Integrated Genome Browser (IGB) to aid in visualization (bioviz.org) (51) .
The reads were aligned using Bowtie (version 1.0.1) (61) with the option -m 1 to exclude reads with ambiguous alignment. In most libraries, over 75% of reads met this criterion. Peaks were called by comparing the IP to the input derived from each sample separately using MACS2 (version 2.1.0) (30) with an effective genome size of 119,667,750 and keep-dup set to auto. Peaks with a negative log 10 Q value of less than 10 were removed. Summit regions were defined by restricting peaks to 100 bp in either direction. Overlapping summit regions from different samples were merged using BEDTools (52), and a consensus peak defined whether this merged overlap included all three cytokinin-treated samples. The 4,861 ARR10 consensus peaks were associated with genes based on the closest downstream gene from each strand within 1.5 kb of the binding summit, as well as accepting any gene to which the peak was internal. This resulted in 4,351 peak-gene relationships, involving 3,577 unique peaks and 4,004 unique genes or "candidate targets" (Dataset S1). Candidate gene targets were correlated with several cytokinin expression datasets (Dataset S2) (11, 20) .
The fold enrichment for ARR10 binding in response to cytokinin (fold enrichment in the BA-treated sample/fold enrichment in the mock sample) was determined using two approaches. In the first approach (BAfactor), the fold enrichment was derived from the MACS2 "bgcmp" function for each sample so as to have a value (fold enrichment = IP/input) even in regions where no peak was called in the mock (−BA) sample. In the second approach (BAfactorLimitedToMockPeaks), the fold enrichment was taken from peaks called by MACS (where there is no peak in the mock sample there is an NA value), this approach yielding values generally similar to BAfactor. For boxplot analysis, the bottom and top of each box represent the 25th and 75th percentile for data expression values, the band in the middle of the box represents the median expression value, and the ends of the box whiskers represent the minimum and maximum expression values for the data.
GO analysis was performed using VirtualPlant 1.3 (virtualplant. bio.nyu.edu/cgi-bin/vpweb/) (53), with additional reference to reviews on hormone signaling elements (1-3, 62, 63 ).
RNA-Seq Analysis of the Cytokinin Response in Roots and Shoots.
RNA-seq to examine the cytokinin response in wild-type seedlings was performed similarly to a previous study that used whole seedlings (20) , but roots and shoots were separated following cytokinin treatment and processed independently. Seedlings were grown on vertical plates with 1× MS agar with 1% (wt/vol) sucrose for 10 d with continuous light. Liquid MS with 5 μM BA dissolved using DMSO (or DMSO without BA as a control) was added to the plants and gently shaken for 2 h. Shoots and roots were separated and frozen in liquid nitrogen. Three biological replicates were collected for each treatment group. RNA was collected using Qiagen kits and sent to the High-Throughput Sequencing Facility at the University of North Carolina at Chapel Hill for library synthesis and sequencing. Arabidopsis libraries were sequenced in a single flow cell for 100 base-paired end reads. Arabidopsis RNAseq sequences were aligned to the A_thaliana_Jun_2009 genome using Bowtie, and differentially expressed genes identified as described (20) . Differential expression was examined in roots and shoots (separately) between treated and untreated samples. In all cases, only genes with at least one read in one of the compared samples were considered. A false discovery rate of 0.05 was used to identify differentially expressed genes. Sequence data are available from the NCBI Sequence Read Archive under BioProject no. PRJNA286779. Dataset S1. Candidate gene targets of ARR10
Dataset S1
The dataset gives gene name (At no.), gene symbol, peak distance from TSS, and description of the gene. The fold enrichment for ARR10 binding is given for a gene-associated peak(s) in the presence and absence of cytokinin.
Dataset S2. Target genes of ARR10

Dataset S2
Targets of ARR10 were based on association with genes transcriptionally regulated by cytokinin. Genes that are DE in response to cytokinin were identified from three RNA-seq and two microarray datasets using wild-type plants. The fold change (log 2 FC) is given for these genes. Also included are data related to a microarray study using the cytokinin-insensitive mutant arr1;10;12, in which genes are identified based on differences in comparison with wild type under the basal and cytokinin-treated states. Also included are genes on the golden list of consistently cytokinin-regulated genes. The fold enrichment for ARR10 binding is given for a gene-associated peak(s) in the presence and absence of cytokinin.
